Monthly Archives: December 2020

Nitrosamine Impurities in Medicinal Products Back to Kinapse blog In 2018, the unexpected discovery of nitrosamine (probable human carcinogen) impurities in several angiotensin receptor blockers (ARBs) triggered a series of regulatory actions [...]

Kinapse welcomes you to ICH Q12 Back to Kinapse blog December 2020 Health Canada has recently released an update on the implementation of ICH Q12 in Canada . The target timeframe for implementation of ICH Q12 has been set [...]